Investical Earnings & investing calendar Earnings & investing calendar
/
SSANTEN PHARMACEUTICAL CO.,LTD. logo
4536TSE Prime

SANTEN PHARMACEUTICAL CO.,LTD.

参天製薬 Yahoo Finance

Recent & upcoming events

Sep 28
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Sep 27
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Aug 6
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 22
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 12
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 5
Earnings 1:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
2027
Jan 28
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 29
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Jul 22
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Oct 14
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar

KPI highlights

FY26
Revenue ¥291.62B YoY -2.8%
Operating income ¥47.80B margin 16.4%
Net income ¥37.37B YoY +3.1%
EPS ¥114 YoY +9.7%
P/E —
ROE 12.8% Equity ratio 70% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥311.00B +6.6%
Operating income ¥49.50B +3.6%
Net income ¥40.00B +7.0%
EPS ¥124 +9.1%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q2
Revenue ¥72.39B¥73.42B¥77.03B¥79.13B——
Operating income ¥12.75B¥12.35B¥11.06B¥2.38B——
Net income ¥10.41B¥8.86B¥7.30B¥123M——
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

国内機関 29.6%海外機関 7.5%アクティビスト 4.2%未開示 56.8%202120222023202420252026
事業法人国内機関海外機関アクティビスト未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

日本マスタートラスト信託銀行株式会社 16.1%日本マスタートラスト信託銀行株式会社（信託口）株式会社日本カストディ銀行（信託口） 6.1%株式会社日本カストディ銀行（信託口）日本生命保険相互会社（常任代理人 日 3.3%日本生命保険相互会社（常任代理人 日本マスタートラスト信託銀行株式会社）GOVERNMENT OF NORW 2.7%GOVERNMENT OF NORWAY（常任代理人 シティバンク、エヌ・エイ東京支店）株式会社三菱UFJ銀行 2.2%株式会社三菱UFJ銀行STATE STREET BANK 2.1%STATE STREET BANK AND TRUST COMPANY 505001（常任代理人　株式会社みずほ銀行決済営業部）JPモルガン証券株式会社 2%JPモルガン証券株式会社小野薬品工業株式会社 1.9%小野薬品工業株式会社202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
日本マスタートラスト信託銀行株式会社（信託口） 51,649,000 16.1% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 19,488,000 6.1% Yuho (EDINET)
NORTHERN TRUST CO.（AVFC）RE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUE EQUITY TRUST 13,443,000 4.2% Yuho (EDINET)
日本生命保険相互会社 10,662,000 3.3% Yuho (EDINET)
NORTHERN TRUST CO. (AVFC) RE U.S. TAX EXEMPTED PENSION FUNDS 9,008,000 2.8% Yuho (EDINET)
GOVERNMENT OF NORWAY 8,580,000 2.7% Yuho (EDINET)
株式会社三菱UFJ銀行 6,989,000 2.2% Yuho (EDINET)
STATE STREET BANK AND TRUST COMPANY 505001 6,586,000 2.1% Yuho (EDINET)
JPモルガン証券株式会社 6,453,000 2.0% Yuho (EDINET)
小野薬品工業株式会社 6,204,000 1.9% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 8.8%
✓ Positive operating cash flow ¥43.50B
✗ ROA improved YoY 8.9% → 8.8%
✓ Operating CF exceeds net income (accrual quality) OCF ¥43.50B / net income ¥37.37B
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 69.9% → 70.2%
✓ Current ratio improved 2.58× → 2.60×
✓ No dilution (shares outstanding did not increase) 342,056,000 → 322,282,000
✓ Gross margin improved 57.0% → 58.2%
✗ Asset turnover improved 0.73× → 0.69×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 70.2%
Current ratio 2.6×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 79%
Latest fiscal year result Profit (net income ¥37.37B)

Performance history

Last 10 years
0億円755億円1,510億円2,265億円3,020億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 1,9912,2492,3402,4162,4962,6632,7903,0203,0002,916
Operating income ——451335129359-30.9385469478
Ordinary income ——————————
Net income 23135232023668.3272-149266363374
Total assets 3,2283,8853,9124,0884,0244,6004,2124,3574,0934,230
Equity 2,5312,8582,9093,0293,0763,3752,9403,0612,8622,970

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ¥56¥87¥79¥59¥17¥68¥-39¥73¥104¥114
ROE 9.0%13.0%11.1%8.0%2.2%8.4%-4.7%8.9%12.2%12.8%
Operating CF 108428329399388460371726609435
Investing CF -282-82.6-29.4-51.8-534-352-268-61.5-82.2-130
Financing CF -287-176-281-127-16755.6-372-340-533-493
FCF -174346300348-145109104665527305

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

Dividend grower ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data